CIK 0000200406 · Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221024240
- Phone
- 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,898,386
- in 3 filings
Net −$16,898,386. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise | +13,072 | $151.41 | $2.0M | 30,066 |
| 2026-11-12 | Forminard Elizabeth EVP, Chief Legal Officer | Sale | −13,072 | $284.39 | $3.7M | 16,994 |
| 2026-11-12 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise · Employee Stock Options (Right to Buy) | −13,072 | 0 | ||
| 2026-09-08 | Pinto Daniel E Director | Grant or award · Deferred Share Units | +113.1 | $276.31 | $31K | 2,445.18 |
| 2026-09-08 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +135.72 | $276.31 | $37K | 6,578.77 |
| 2026-09-08 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +180.96 | $276.31 | $50K | 16,049.42 |
| 2026-09-02 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise | +11,070 | $131.94 | $1.5M | 36,517 |
| 2026-09-02 | Schmid Timothy EVP, WW Chair, MedTech | Sale | −11,070 | $274.74 | $3.0M | 25,447 |
| 2026-09-02 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise | +22,527 | $151.41 | $3.4M | 47,974 |
| 2026-09-02 | Schmid Timothy EVP, WW Chair, MedTech | Sale | −22,527 | $274.74 | $6.2M | 25,447 |
| 2026-09-02 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise · Employee Stock Options (Right to Buy) | −11,070 | 0 | ||
| 2026-09-02 | Schmid Timothy EVP, WW Chair, MedTech | Option exercise · Employee Stock Options (Right to Buy) | −22,527 | 0 | ||
| 2026-08-17 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise | +15,000 | $115.67 | $1.7M | 209,451 |
| 2026-08-17 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Sale | −15,000 | $263.36 | $4.0M | 194,451 |
| 2026-08-17 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise · Employee Stock Options (Right to Buy) | −15,000 | 28,712 | ||
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board | Option exercise | +123,291 | $115.67 | $14.3M | 399,258 |
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board | Sale | −20,976 | $262.00 | $5.5M | 378,282 |
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board | Sale | −102,315 | $261.00 | $26.7M | 275,967 |
| 2026-08-13 | Duato Joaquin CEO and Chairman of the Board | Option exercise · Employee Stock Options (Right to Buy) | −123,291 | 0 | ||
| 2026-08-06 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise | +9,344 | $131.94 | $1.2M | 32,912 |
Page 1 of 19 · 365 trades